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Summary
Formation of synapses requires specific cellular inter-
actions that organize pre- and postsynaptic compart-
ments. The neuroligin-neurexin complex mediates
heterophilic adhesion and can trigger assembly of glu-
tamatergic and GABAergic synapses in cultured hip-
pocampal neurons. Both neuroligins and neurexins
are encoded by multiple genes. Alternative splicing
generates large numbers of isoforms, which may en-
gage in selective axo-dendritic interactions. We ex-
ploredwhether alternative splicing of the postsynaptic
neuroligins modifies their activity toward glutamater-
gic and GABAergic axons. We find that small extracel-
lular splice insertions restrict the function of neuro-
ligin-1 and -2 to glutamatergic and GABAergic
contacts and alter interactionwith presynaptic neurex-
ins. The neuroligin isoforms associated with GABAer-
gic contacts bind to neurexin-1a and a subset of neu-
rexin-1bs. In turn, these neurexin isoforms induce
GABAergic but not glutamatergic postsynaptic differ-
entiation. Our findings suggest that alternative splic-
ing plays a central role in regulating selective extracel-
lular interactions through the neuroligin-neurexin
complex at glutamatergic and GABAergic synapses.
Introduction
The nervous system consists of an intricate network of
neurons that are connected by synaptic junctions. Un-
derstanding how selective wiring between specific syn-
aptic partners is achieved represents a major question
in neurodevelopment. Sperry proposed that chemoaf-
finity labels presented at the surface of individual cells
might direct selective neuronal growth and connectivity
(Sperry, 1963). Adhesion molecules represent attractive
candidates for mediating such selective cell-cell interac-
tions (Benson et al., 2001; Scheiffele, 2003; Yamagata
et al., 2003; Waites et al., 2005). In particular, there has
been considerable interest in gene families comprising
large numbers of adhesive protein isoforms that could
encode selective axon-target interactions at different
synapses (Missler and Su¨dhof, 1998; Schmucker and
Flanagan, 2004; Weiner et al., 2005).
The neuroligin-neurexin protein complex is a hetero-
philic adhesion system that might mediate selective
trans-synaptic interactions. Neurexins represent one of
the most diverse protein families in the mammalian
*Correspondence: ps2018@columbia.edunervous system, with over 1000 isoforms expressed
from three neurexin genes (NRXN1, -2, and -3) (Ushkar-
yov et al., 1992; Ullrich et al., 1995). This molecular diver-
sity is generated by expression from two alternative
promoters that yield a long a- and a shorter b-neurexin
transcript and by alternative splicing at up to five sites
in the neurexin pre-mRNA (splice sites 1 through 5)
(Missler et al., 1998). Biochemical fractionation and im-
munolocalization studies with pan-neurexin antibodies
revealed a concentration of neurexins at synapses in
the hippocampus, suggesting that they mediate synap-
tic interactions (Ushkaryov et al., 1992; Butz et al., 1998;
Dean et al., 2003). Neuroligins were identified as splice
isoform-specific neurexin ligands that are encoded by
five genes (NLGN1, -2, -3, -4, and -4Y) (Ichtchenko
et al., 1995, 1996; Bolliger et al., 2001). So far, only NL1
and -2 have been analyzed in detail at the cellular level.
Immunolocalization studies suggested that NL1 is pri-
marily localized to the postsynaptic side of glutamater-
gic synapses, whereas NL2 is preferentially targeted to
GABAergic synapses (Song et al., 1999; Varoqueaux
et al., 2004). Additional studies revealed that a fraction
of endogenous NL1 might be localized to GABAergic
synapses (Levinson et al., 2005). Overexpression and
loss-of-function experiments in cultured neurons re-
vealed that NL1 and NL2 isoforms can promote the as-
sembly of glutamatergic and GABAergic synapses by
bidirectional signaling in vitro (Scheiffele et al., 2000;
Graf et al., 2004; Prange et al., 2004; Chih et al., 2005;
Levinson et al., 2005; Sara et al., 2005). These experi-
ments highlighted a potent activity of the neuroligin-
neurexin complex in organizing pre- and postsynaptic
domains through trans-synaptic interactions.
Neuroligins are alternatively spliced in their ectodo-
mains. Inclusion of short alternative exons (20 and 9
amino acids in length) at two sites (designated A and
B, respectively) generates four potential NL1 variants
[NL1(2), NL1A, NL1B, and NL1AB; see Figure 1] (Ichtch-
enko et al., 1996). NL2 undergoes a similar splicing event
at the first site, thereby generating two different iso-
forms [NL2(2) and NL2A]. When tested in synapse-in-
duction assays with heterologous cells, all NL1 isoforms
have the ability to induce clustering of synaptic vesicles
in pontine axons (Scheiffele et al., 2000). A more recent
study reported that inclusion of a splice insertion at
the B site in NL1 alters the interaction with neurexins
(Boucard et al., 2005). Specifically, the B insertion in
NL1 prevents binding to those b-NRX isoforms that con-
tain a splice insertion at site 4. Moreover, the B insertion
prevents binding to a-NRX isoforms (Boucard et al.,
2005). However, the cellular consequences of these
selective interactions are incompletely understood.
One important question that emerged from the previ-
ous work is how the specificity of neuroligin isoforms for
glutamatergic and GABAergic synapses is encoded. In
principle, such specificity could arise from selective
extracellular interactions between specific pairs of neu-
roligin and neurexin isoforms. In an alternative model,
extracellular neuroligin-neurexin interactions might be
rather unselective, and neuroligin isoforms could be
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172Figure 1. Alternative Splicing of Neuroligins Alters Targeting to Glutamatergic and GABAergic Synaptic Contacts
(A) Diagram of insertions A and B in NL1 and -2. RT-PCR analysis with primers flanking the splice insertion sites on RNA isolated from rat hip-
pocampus, cortex, and cerebellum. b-actin was amplified as a positive control. Products containing (+) and lacking (2) the splice insertion are
marked. Molecular weight markers are in base pairs. (B) Dendritic segments of cultured hippocampal neurons expressing low levels of trans-
fected neuroligin splice variants. At 10 DIV, cells were transfected with NL1 lacking splice insertions A and B [NL1(2)], containing a single inser-
tion (NL1A and NL1B), containing both splice insertions (NL1AB), or with constructs for NL2 lacking or containing a splice insertion [NL2(2) and
NL2A, respectively]. Three days after transfection, cells were triple immunostained with antibodies to the HA-eptiope on the neuroligin isoforms
(green), VGAT (red), and VGlut1 (magenta). Some immunoreactive dendritic spine heads are marked with arrows, and shaft synapses are marked
with arrowheads. The quantitation shows the percent association of puncta formed by the neuroligin splice variants with VGAT- and VGlut1-pos-
itive structures (shown in red and blue, respectively; n = 10 cells and >2000 puncta for each condition, ANOVA p < 0.0001). Scale bar, 5 mm. (C)
Inclusion of the NL2 splice insertion A was suppressed by a morpholino oligonucleotide (MO) complementary to the splice donor site of the exon
encoding the NL2A insertion. RT-PCR products from two independent culture wells (NL2A MO) are compared to an untreated (None) and a culture
control MO (Con). No effect on splicing of NL1A was observed (lower panel). (D) Hippocampal neurons were transfected with control morpholino
oligos (MO) or NL2A-specific MO and stained with NL2 (red) and VGlut1 (green) antibodies (n = 10 fields for each condition, t test p < 0.0001).
Scale bar, 5 mm. Error bars show mean 6 SD.recruited to glutamatergic versus GABAergic sites by in-
teraction with synapse-specific cytoplasmic scaffolds.
So far, there is only direct support for the latter,
cytoplasmic specificity mechanism: overexpression of
PSD-95, a glutamatergic scaffolding protein, recruits
endogenous NL2 protein to glutamatergic synapses,
and similarly, expression of PSD-95 has been shown
to restrict NL1 to glutamatergic sites (Graf et al., 2004;
Prange et al., 2004; Levinson et al., 2005). However,the role of individual splice isoforms of neuroligins in
synaptic selectivity has not been analyzed.
In the present study, we explored whether specific
neuroligin splice isoforms differ in their targeting to glu-
tamatergic or GABAergic axo-dendritic contacts and
whether specific neuroligin and neurexin splice isoforms
exhibit functional selectivity. We find that alternative
splicing in the NL1 extracellular domain controls the lo-
calization and synapse-inducing activity of the protein
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find that this differential activity of neuroligin proteins
is mediated through differential interaction with specific
neurexin splice variants. These data provide strong evi-
dence that the molecular diversity of the neuroligin and
neurexin gene families mediates selective interactions
at CNS synapses.
Results
Expression of Neuroligin Splice Isoforms
To begin analyzing the selectivity of neuroligin-neurexin
isoform interactions, we examined the expression of
NL1 and -2 isoforms by RT-PCR. NL1 pre-mRNA can
be alternatively spliced in sequences encoding the ex-
tracellular domain at two positions, designated A and
B (Figure 1A) (Ichtchenko et al., 1996; Scheiffele et al.,
2000). Analysis with primers flanking the splice insertion
sites indicated the presence of mRNAs containing and
lacking splice insertion A and B in different brain areas
(Figure 1A). While mRNAs with and without the A inser-
tion were detected at similar levels, there was only
a small but significant pool of NL1 mRNA lacking the B
insertion. For NL2, we observed RT-PCR products con-
taining and lacking the splice insertion in site A, with the
A(+) form being more abundant than the A(2) form
(Figure 1A). NL2-specific primers flanking the position
analogous to splice site B in NL1 did not amplify an in-
sertion-containing product (data not shown), consistent
with the previous suggestion that NL2 is not alternatively
spliced at this position (Ichtchenko et al., 1996). RT-PCR
performed with RNA isolated from cultured hippocam-
pal neurons revealed similar incorporation of A and B
in both neuroligins (data not shown, but see Figure 1C
below). This suggests that multiple NL1 and -2 splice
variants are expressed in vitro and in vivo.
It is unknown whether alternative splicing in the extra-
cellular domain alters neuroligin localization. To address
this question, we established conditions to express
epitope-tagged forms of all NL1 and -2 splice variants
at low levels in cultured hippocampal neurons. Under
these conditions, neuroligin expression did not result
in a significant increase in the density of presynaptic ter-
minals formed on the transfected cells (n = 10, ANOVA
p > 0.05), in contrast to significant overexpression,
which results in a marked increase of presynaptic termi-
nal density (Dean et al., 2003; Prange et al., 2004; Bou-
card et al., 2005; Chih et al., 2005). The synaptic localiza-
tion of the dendritic neuroligin isoforms was then
assessed by triple staining with antibodies to the HA-
epitope tag in neuroligin and antibodies to the presyn-
aptic markers of glutamatergic (VGlut1) and GABAergic
(VGAT) synapses. Figure 1B shows representative im-
ages of the localization of the epitope-tagged proteins
along segments of dendrites. As judged by overlap
with the combination of both presynaptic markers,
about 70% of punctate structures formed by all postsyn-
aptic neuroligin isoforms were concentrated at synaptic
contacts. However, the NL1 splice isoforms greatly dif-
fered in their apposition to vGlut1- and VGAT-positive
terminals (Figure 1B). NL1(2) that lacks both splice in-
sertions showed comparable overlap with vGlut1- and
VGAT-positive sites (VGlut1:VGAT, 48:52% 6 3%).
NL1A that contains insertion A was preferentially tar-geted to VGAT-positive structures on the dendritic shaft
(28:72% 6 2%). In contrast, NL1B was targeted to
vGlut1-positive sites and was often concentrated in
spine heads (83:17% 6 2%). Inclusion of both splice in-
sertions (NL1AB) resulted in a protein that was targeted
to vGlut1-positive sites like NL1B (80:20% 6 3%), sug-
gesting that the presence of the B insertion overrides
the activity of the A insertion (Figure 1B).
Synaptic localization of NL2 splice variants followed
a similar pattern. NL2 lacking a splice insertion was sim-
ilarly distributed over vGlut1- and VGAT-positive puncta,
whereas inclusion of insertion A increased localization at
VGAT-positive sites (Figure 1B). Interestingly, cells
expressing NL2A showed a slight decrease in the density
of VGlut1-positive puncta (vGlut1 puncta/10 mm den-
drite: GFP = 5.62 6 1.14, NL2A = 3.28 6 1.16, n = 10, p
< 0.05, no statistically significant change in VGAT puncta
density). This suggests that subtly altering the abun-
dance of this neuroligin splice variant may alter the ratio
of glutamatergic and GABAergic contacts formed on the
cell. However, low-level expression of any of the other
neuroligin splice variants did not result in statistically
significant changes in the glutamatergic:GABAergic
contact ratio under our experimental conditions.
To test directly whether the A insertion in endogenous
NL2 contributes to the selective association of the pro-
tein with GABAergic contacts, we used an antisense
morpholino-oligonucleotide approach to induce exon
skipping (Schmajuk et al., 1999; Gebski et al., 2003).
We designed a morpholino oligo that targets the splice
donor side of the exon encoding insert A (Figure 1C).
Delivery of this oligo into cultured hippocampal neurons
specifically reduced inclusion of the A sequences in the
NL2 mRNA but did not affect the A insertion in NL1
(Figure 1C). Importantly, in neurons treated with the
NL2A-specific morpholino oligonucleotide, the endoge-
nous NL2 showed increased association with the gluta-
matergic marker vGlut1 (Figure 1D). This further sup-
ports an important function of the A insertion in the
synaptic specificity of NL2. In summary, these findings
suggest a critical role for alternative splicing in the asso-
ciation of the NL1 and -2 isoforms with glutamatergic and
GABAergic synaptic terminals in hippocampal neurons.
Neuroligin Splice Variants Have Different
Synapse-Inducing Activities
To test whether the different neuroligin splice isoforms
have selective activities in inducing the assembly of glu-
tamatergic or GABAergic presynaptic terminals, we over-
expressed them in cultured hippocampal neurons. As in
the localization experiments, NL1 splice variants differed
in the induction of glutamatergic and GABAergic termi-
nals (Figure 2). NL1(2) and NL1A significantly increased
the density of both glutamatergic and GABAergic termi-
nals. In contrast, NL1B and NL1AB greatly increased
glutamatergic terminal density but had little effect on GA-
BAergic terminals. This suggests that the B insertion se-
quence prevents activity of NL1 toward GABAergic
axons. Previous work demonstrated that overexpression
of NL1AB promotes the formation of dendritic spines
(Boucard et al., 2005; Chih et al., 2005; Sara et al., 2005).
However, the selectivity of NL1AB for induction of gluta-
matergic synapses is not a secondary consequence of
alterations in dendritic morphology and cell-cell contact.
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174Figure 2. Presence of the B Insertion in Neuroligin-1 Controls Activity in Glutamatergic Synapse Induction
(A) Dendritic segments of cultured hippocampal neurons overexpressing NL1 variants. Cultures were transfected at 10 DIV and analyzed 3 days
later. Cells were immunostained with antibodies to the HA-epitope on the neuroligin isoforms (green), VGAT (red), and VGlut1 (blue). Scale bar,
5 mm. (B) Density of presynaptic vGlut1- and VGAT-positive puncta on cells overexpressing EGFP, NL1(2), NL1A, NL1B, or NL1AB (n = 10 cells for
each condition, ANOVA p < 0.0001). (C) Glycosylation of the B insertion is essential for selective activity at glutamatergic synapses. The synapse-
inducing activity of the mutant NL1AB (N303A) in which the asparagine of the N-glycosylation site was mutated to alanine was compared to
NL1AB and NL1A (n = 10 cells for each condition, ANOVA p < 0.0001). Error bars show mean 6 SD.A large proportion of the NL1AB-induced vGlut1-positive
sites were localized to dendritic shafts, indicating that it is
the identity of the extracellular domain and not the pres-
ence of spines that directs the selective assembly of glu-
tamatergic terminals in response to NL1AB. Boucard
et al. demonstrated that synapsin-positive vesicle clus-
ters induced by overexpression of NL1(2) in cultured hip-
pocampal neurons were enlarged as compared to NL1B
(Boucard et al., 2005). Using neurotransmitter-specific
vesicle markers vGlut1 and VGAT, we found a significant
enlargement of both VGAT- and vGlut1-positive puncta in
NL1(2)-expressing cells, whereas NL1B primarily
increased vGlut1-positive puncta size but had little effect
on VGAT-positive puncta (see Figure S1 in the Supple-
mental Data available online). This further confirms
a synapse-specific activity of the NL1 variants.
The B insertion sequence in NL1 consist of only nine
amino acids but contains a consensus sequence for
N-glycosylation that is modified with complex-type gly-
cans (Comoletti et al., 2003; Hoffman et al., 2004). To test
whether the presence of N-glycans in the B insertion
was critical for restricting NL1 function to glutamatergic
synapses, we mutated asparagine 303 to alanine and
expressed the mutant protein in dissociated hippocam-
pal neurons (Figure 2). Removal of the N-glycosylation
site greatly increased the activity of NL1AB for inductionof VGAT-positive presynaptic terminals, thereby shifting
the synapse-inducing activity of NL1AB to a pattern
similar to NL1A (Figure 2B). Most likely, the large carbo-
hydrate structure in the B splice insert inhibits NL1B
activity toward GABAergic synapse induction, possibly
by hindering interactions with ligands. Such a mecha-
nism might also explain why the presence of the B inser-
tion is dominant over the A insertion, as observed in the
low-expression experiments (Figure 1).
The NL2(2) and NL2A isoforms showed comparable
induction of vGlut1 and VGAT-positive terminals when
overexpressed (Figure 3).To further test the relevance
of the B insertion for the selectivity for glutamatergic syn-
apses, we transplanted the B sequence of NL1 into NL2,
which normally is not alternatively spliced at this posi-
tion. When tested in the synapse-induction assay in hip-
pocampal neurons, the resulting NL2B and NL2AB vari-
ants lost their ability to induce GABAergic presynaptic
terminals (Figure 3). This strongly supports the idea that
the presence of a splice insertion at the B site restricts
the activity of neuroligins to glutamatergic synapses.
Specific Neurexin Variants with Selective Activity
for GABAergic Synapse Formation
We hypothesized that the differential synapse-inducing
activities of neuroligin splice variants might be caused
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175Figure 3. Introduction of the B Insertion into Neuroligin-2 Prevents Induction of GABAergic Presynaptic Terminals
(A) The NL2 splice variants NL2(2) and NL2A and the artificial variants into which the B exon from NL1 had been inserted (NL2B and NL2AB) were
overexpressed in cultured hippocampal neurons (10 + 3 DIV). Cells were immunostained with antibodies to the HA-epitope on the neuroligin
isoforms, VGAT, and VGlut1. Scale bar, 5 mm. (B) Density of presynaptic puncta on overexpressing cells was quantified for ten cells as described
in Experimental Procedures (n = 10 cells for each condition, ANOVA p < 0.0001). Error bars show mean 6 SD.by differential interaction with neurexin isoforms ex-
pressed on glutamatergic and GABAergic axons. To
probe whether endogenous neurexins are indeed re-
cruited by neuroligin isoforms, we performed immuno-
histochemistry with pan-neurexin antibodies. We ob-
served a strong increase in the neurexin concentration
at glutamatergic and GABAergic terminals in response
to expression of NL1AB and NL2A, respectively
(Figure S2). To begin to explore differential binding of
neurexins to neuroligin variants, we focused on splice
site 4 of NRX1, which has been shown to be a critical
regulator of neuroligin-neurexin interactions (Ichtch-
enko et al., 1995; Boucard et al., 2005; Graf et al.,
2006). When tested in binding assays with neuroligin-
expressing cells, recombinant NRX1b containing and
lacking an insertion in site 4 [NRX1b4(+) and -4(2)]
showed differential interaction with neuroligins. While
NRX1b4(2) bound similarly to cells expressing any of
the NL1 and -2 splice variants, the isoform containing
an insertion in site 4 [NRX1b4(+)] did not bind to NL1B
and NL1AB, but efficiently interacted with NL1(2),
NL1A, NL2(2), and NL2A (Figure S3). These findings
confirmed a recent report that demonstrated that the
presence of splice insertion B in NL1 prevents interac-
tion with NRX1b4(+) (Boucard et al., 2005). In the same
study, Boucard et al. also showed that NL1 lacking
insertion B can interact with NRX1a, regardless of
whether the neurexin contains or lacks splice insertion 4.
This selectivity imposed by the B insertion in NL1 re-
quires the N-glycosylation site in B (Boucard et al.,
2005). Based on these biochemical interactions and the
selective activities of neuroligin isoforms observed in
our cellular assays, we predicted that GABAergic axons
should employ neurexin variants that bind to NL1A and
NL2A but not to NL1AB and NL1B. Accordingly,
NRX1b4(+) and a-neurexins are candidate presynaptic
binding partners for neuroligins at GABAergic synapses.
To probe for a selectivity in synapse induction by a-
versus b-neurexins and neurexins alternatively spliced
at site 4, we examined the NRX1a4(2), NRX1b4(2),
and NRX1b4(+) variants in more detail. We employed
a mixed-culture assay that measures the assembly ofpostsynaptic structures in response to contact with
non-neuronal cells transfected with a single neurexin
isoform (Graf et al., 2004). The differential binding of
NRX1b4(+) and NRX1a4(2) to the GABAergic neuroligins
predicts that these neurexins should exclusively pro-
mote GABAergic postsynaptic differentiation. We ex-
pressed NRX1b4(+), NRX1a4(2), and as a control,
NRX1b4(2) in COS cells and added these cells to cul-
tured hippocampal neurons. As previously shown (Graf
et al., 2004; Nam and Chen, 2005), NRX1b4(2) induced
glutamatergic and GABAergic postsynaptic structures
positive for PSD-95 and gephyrin, respectively (Figure 4).
In contrast, NRX1b4(+) and NRX1a4(2) exclusively trig-
gered the assembly of a gephyrin-containing postsyn-
aptic scaffold. These structures were VGAT negative,
confirming that they were induced by the heterologous
cells and did not represent pre-existing neuron-neuron
contacts. Moreover, the GABAergic postsynaptic sites
recruited endogenous NL2 (Figure S4), which according
to our RT-PCR analysis is the most abundant binding
partner for these neurexin isoforms in dissociated hip-
pocampal neurons. These findings suggest a selective
activity of two classes of neurexins in the induction of
GABAergic synapses in hippocampal neurons: a-neu-
rexins and the subset of b-neurexins containing a splice
insertion in site 4.
To confirm a differential activity of neurexin splice var-
iants, we used the extracellular domain of NRX1b as a
blocking reagent. In previous studies, we demonstrated
that a recombinant NRX1b4(2)-Fc fusion protein blocked
glutamatergic synapse formation between cerebellar
neurons, presumably by competing with the endoge-
nous neurexin isoforms for binding partners (Scheiffele
et al., 2000). In the same assay, NRX1b4(+)-Fc did not
show any effect on glutamatergic synapse assembly.
When applied to hippocampal neurons, NRX1b4(2)-Fc
reduced the number of vGlut1- and VGAT-positive
puncta (Figure 4E). In contrast, NRX1b4(+)-Fc selectively
reduced the density of VGAT-positive terminals but had
no effect on the density of vGlut1-positive puncta. This
further supports an isoform-specific role for neurexins
in the assembly of GABAergic terminals.
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(A and B) COS cells expressing EGFP, NRX1b4(2), NRX1b4(+), or NRX1a4(2) were added to cultured hippocampal neurons at 10 DIV and ana-
lyzed 3 days later. The neurexin variants were detected with antibodies to the HA-epitope tag fused to the protein (blue) and protein accumulation
in neurons was detected with antibodies to PSD-95 (in [A]) or gephyrin (in [B]) to mark glutamatergic and GABAergic postsynaptic structures,
respectively (red). Postsynaptic structures in contact with the COS cells that do not contain presynaptic markers (VGlut1 or VGAT) are visualized
as pink in the merge image. Scale bar, 10 mm. (C and D) Quantitation of clusters of postsynaptic markers PSD-95 and gephyrin induced by neu-
rexin-expressing COS cells. The percentage of COS cell contact area was scored that is positive for the postsynaptic marker PSD-95 or gephyrin
but negative for the corresponding presynaptic marker (VGlut1 or VGAT, respectively; n = 10 cells, for NRX1b4(+) PSD-95 p = 0.28; gephyrin
p < 0.001). (E) Hippocampal neurons were transfected with an EGFP expression plasmid, and recombinant NRX1b4(2) and NRX1b4(+)-Fc fusion
proteins were added to the culture medium at 6 DIV. The density of presynaptic vesicle clusters positive for VGlut1 and VGAT was quantified
6 days later (n = 10, ANOVA p < 0.001). Error bars show mean 6 SD.Discussion
Our studies reveal a central role for alternative splicing in
the functional regulation of the neuroligin-neurexin com-
plex at glutamatergic and GABAergic synapses. Selec-
tive interactions of each partner in this trans-synaptic
complex are regulated by alternative splicing decisions.
For GABAergic synapses, we observed a selective syn-
apse-inducing activity for presynaptic NRX1a4(2) and
NRX1b4(+) that can interact with postsynaptic NL1(2),
NL1A, NL2(2), and NL2A isoforms (with NL2A being
the most abundant ligand in hippocampal neurons). In
contrast, we discovered that the B insertion in NL1 var-
iants NL1B and NL1AB restricts NL1 function to gluta-
matergic synapses where they can interact with b-neu-
rexin variants that lack an insertion at site 4. These
findings identify neuroligin and neurexin splice variants
with selective functions at glutamatergic and GABAergic
synapses. In addition to these synapse-selective iso-
forms, our analysis also revealed that there are neurexin
and neuroligin isoforms such as NRX1b4(2), NL1(2),
and NL2(2) that promote both glutamatergic and
GABAergic synaptic differentiation in our assay systems.
The finding that a subset of neurexin isoforms shows
selective activity in the induction of GABAergic synap-
ses is of particular interest considering that only few
transmembrane components of GABAergic synapses
are known thus far (Moss and Smart, 2001). Our analysis
with pan-neurexin antibodies directly demonstrates
concentration of endogenous neurexins at GABA syn-apses. The functional assays identified two classes of
neurexin variants that exclusively induce assembly of
GABAergic postsynaptic sites: a-neurexins and the sub-
set of b-neurexins containing the splice insertion at site
4. Consistent with an important function of a-neurexins
in GABAergic synapse assembly, a-neurexin triple
knockout mice show a 50% reduction in the density of
GABAergic synapses in the neocortex (Missler et al.,
2003). For NRX1b4(+), our data demonstrate that alter-
native splicing plays a central role in controlling the in-
teraction with neuroligins and the functional selectivity.
The 30 amino acid splice insertion in NRX1b4(+) con-
verts the unselective NRX1b4(2) isoform into a protein
with synapse-selective function. A recent study by
Graf et al. suggested that the 4(+) insertion decreases
but does not abolish the activity of NRX1b4(+) toward
glutamatergic postsynaptic assembly as well as its
binding to NL1AB (Graf et al., 2006). In contrast, our re-
sults as well as those of Boucard et al. suggest that the
4(+) isoform lacks significant affinity for NL1AB, and our
functional assays do not show accumulation of postsyn-
aptic glutamatergic components above background
levels. These differences might be attributed to different
protein expression levels in the gain-of-function assays.
Most importantly, our loss-of-function experiments
show that recombinant NRX1b4(+) perturbs GABAergic
presynaptic vesicle clustering but does not alter accu-
mulation of glutamatergic markers, therefore confirming
a synapse-specific activity of this neurexin variant. With
respect to the postsynaptic neuroligin isoforms, we
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in the extracellular domain of NL1 and NL2 increases the
association of the protein with GABAergic presynaptic
terminals. How the presence of the A insertion alters
interaction with specific neurexins at GABAergic synap-
ses remains to be investigated.
While these experiments highlight the role for alterna-
tive splicing in controlling synapse-specific activities of
neuroligin and neurexin isoforms, the trans-synaptic
neuroligin-neurexin adhesion code is likely to be com-
plex. The neurexin isoforms NRX1b4(+) and NRX1a4(2)
are not restricted to inhibitory interneurons but are
also expressed in glutamatergic cells (Ullrich et al.,
1995). Moreover, a-neurexin triple knockout mice also
show defects in glutamatergic transmission (Missler
et al., 2003). This argues against a simple model where
specific cell types would express only a single neurexin
variant that is directly linked to the neurotransmitter
phenotype. More likely, different neuronal populations
might employ multiple neurexin isoforms that act in
combination with other synapse-specific factors. Future
work will be required to clarify this; however, our data
strongly suggest that splice isoform-specific neuroligin-
neurexin interactions are differentially employed at
GABAergic and glutamatergic synapses.
For NL1 and NL2, previous in situ hybridization stud-
ies suggest that both isoforms are coexpressed in
many neuronal cell types (Scheiffele et al., 2000; Varo-
queaux et al., 2004), which is not surprising considering
that most cells receive both glutamatergic and GABAer-
gic inputs. However, additional analysis of NL1 and -2
splice isoform expression at the single-cell level might
reveal whether specific variants are differentially em-
ployed at some synapses. The selective extracellular in-
teractions mediated by specific neuroligin and neurexin
splice isoforms are likely to be further regulated by the
previously proposed cytoplasmic mechanisms in con-
trolling neuroligin localization and function (Prange
et al., 2004; Levinson and El-Husseini, 2005). We identi-
fied NL1(2) and NL2(2) as two neuroligin splice variants
with little apparent preference for specific synaptic con-
tacts. The function of these variants might be most
strongly dependent on interactions with the cytoplasmic
scaffold, e.g., PSD-95. In contrast, NL1B and NL1AB
show little activity toward GABAergic presynaptic termi-
nals in the synapse-induction assays; these isoforms
therefore are unlikely to be regulated through a mecha-
nism depending on interactions with the cytoplasmic
postsynaptic scaffold.
Utilizing specific variants of a single synaptic adhesion
system at glutamatergic and GABAergic synapses has
some interesting implications. The divergent extracellu-
lar interactions may contribute to cell-cell recognition
events, whereas common intracellular domains may
couple these interactions to similar synapse assembly
or maturation pathways. Our experiments show that al-
ternative splicing of neuroligins regulates the specificity
of their synapse-inducing activities toward glutamater-
gic and GABAergic axons. This mechanism may be em-
ployed to rapidly alter synaptic interactions in response
to signaling, for example by switching NL1 association
from glutamatergic to GABAergic synapses by exclusion
of the B insertion. Further analysis of the significant num-
ber of additional neuroligin and neurexin isoforms shoulddetermine whether other selective interactions are en-
coded by this neuronal receptor system and whether
such interactions also contribute to selective trans-syn-
aptic interactions at different types of central synapses.
Experimental Procedures
Neuronal Culture Assays
Dissociated cultures of hippocampal neurons were prepared from
E18 rats, plated on poly-D-lysine-coated glass coverslips at a den-
sity of 30,000/cm2, and maintained in neurobasal medium with B27
supplement (Invitrogen). Transfections were carried out with Lipo-
fectamine 2000 (Invitrogen) as described previously (Chih et al.,
2005). For low expression of neuroligin splice forms, 75 ng of DNA
was used per coverslip in a 24-well plate, for overexpression exper-
iments, 150 ng of DNA (see Supplemental Data for details on the
DNA vectors).
Morpholino oligonucleotides (MOs) used to increase skipping of
the A insertion in NL2 were designed based on methods previously
used for other target genes (Schmajuk et al., 1999; Gebski et al.,
2003). The following MOs were used (GeneTools): NL2A, 50-ATTTTT
AAATCTACCTGTGTCTGGC-30; negative control oligo, 50-CCTCTT
ACCTCAGTTACAATTTATA-30. MOs were added to individual wells
in a 24-well plate containing 500 ml of culture medium at final concen-
tration of 10 mM with gentle mixing. Then 4 ml of Endoporter (Gene-
Tools) was added to each well. Neurons were treated at 6 DIV and
incubated for 4 days.
See Supplemental Data for additional information on histochemis-
try and image acquisition.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/51/2/171/DC1/.
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